AMAT
52
3
AZO
42
-3
BAX
38
-12
NI
65
-2
AIZ
78
2
HPE
75
7
AME
72
6
PRU
62
2
TXT
82
4
KIM
50
-3
TJX
53
-9
AIV
37
-2
MA
55
4
ADT
50
2
MMC
53
-5
ADM
47
2
NUE
58
7
MAT
50
-5
CFG
95
2
SCHW
64
6
AMAT
52
3
AZO
42
-3
BAX
38
-12
NI
65
-2
AIZ
78
2
HPE
75
7
AME
72
6
PRU
62
2
TXT
82
4
KIM
50
-3
TJX
53
-9
AIV
37
-2
MA
55
4
ADT
50
2
MMC
53
-5
ADM
47
2
NUE
58
7
MAT
50
-5
CFG
95
2
SCHW
64
6
Financhill
Back

STF Tactical Growth & Income ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
41

TUGN
STF Tactical Growth & Income ETF

Last Price:
$25.64
Seasonality Move:
-1.93%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
41
STF Tactical Growth & Income ETF (TUGN) is a Sell

Is STF Tactical Growth & Income ETF a Buy, Sell or Hold?

  • The current STF Tactical Growth & Income ETF [TUGN] share price is $25.65. The Score for TUGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TUGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TUGN Stock Price Chart

What is STF Tactical Growth & Income ETF's stock price today?

  • The STF Tactical Growth & Income ETF share price today is $25.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TUGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

TUGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.77 Buy
Relative Strength Index (14 RSI): 49.14 Sell
Chaikin Money Flow: 7677 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.3 - 25.9) Buy
Bollinger Bands (100): (25.14 - 26.24) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

TUGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.55 Buy
20-day SMA: 25.64 Buy
50-day SMA: 25.91 Sell
200-day SMA: 24.3 Buy
8-day EMA: 13.45 Buy
20-day EMA: 6.58 Buy
50-day EMA: 2.87 Buy
200-day EMA: 0.75 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

STF Tactical Growth & Income ETF Earnings Growth & TUGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

STF Tactical Growth & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):